We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Increased Baseline C-Reactive Protein Linked to Heightened Infection Risk

By LabMedica International staff writers
Posted on 01 Feb 2016
Print article
Image:  The ABI PRISM 7900HT Sequence Detection System (Photo courtesy of the University of Geneva).
Image: The ABI PRISM 7900HT Sequence Detection System (Photo courtesy of the University of Geneva).
C-reactive protein (CRP) is an innate immune system recognition and effector molecule that plays a role in both the innate response and as an adaptor to the complex immune system.

In an infectious disease or inflammatory state, rapid CRP upregulation occurs and the most pronounced increases are primarily seen in infectious diseases and the acute-phase CRP increases rapidly during an infection.

Clinical biochemists at the Copenhagen University Hospital (Denmark) studied 9,660 individuals from a prospective general population cohort, including 3,592 in whom infectious disease developed, and another 60,896 individuals from a cross-sectional general population study, of whom 13,332 developed infectious disease; 55% were women, and the mean age was 57 years. Infectious diseases were classified as bacterial, viral, or other.

The ABI Prism 7900HT SDS (Applied Biosystems; Foster City, CA, USA) was used to genotype for four single nucleotide polymorphisms in the CRP gene (rs3091244, rs1130864, rs1205, and rs3093077). Genotyping was verified by DNA sequencing in more than 30 individuals with each genotype. CRP was measured with high-sensitivity nephelometry or turbidimetry assays. Covariates for adjustments were chosen on the basis of known influence on plasma CRP concentrations or risk of infection.

The teams found that individuals with CRP greater than 3 mg/L had 1.2 and 1.7 times increased risk of infectious disease, in the prospective general population cohort and the cross-sectional general population study, respectively, compared with individuals with CRP of less than 1 mg/L. In the combined populations, individuals in the highest CRP tertile compared with the lowest had an increased risk of bacterial diseases, but not viral, mycosis, and parasitic diseases. The increased risk was mainly carried by pneumonia, sepsis, and particularly gram-negative infections. None of the genotype combinations examined conferred an increased risk of infectious disease.

The authors concluded that chronic low-level increased plasma CRP concentrations to be associated with an increased risk of bacterial infections, and in particular gram-negative infections. However, genotypes associated with increases in plasma CRP concentrations were not associated with increased risk of infection. The study was published on December 31, 2015, in the journal Clinical Chemistry.

Related Links:

Copenhagen University Hospital 
Applied Biosystems


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.